Increased Risk for Adverse Outcomes With Mild Pulmonary Hypertension in HFpEF
Viewing mild pulmonary hypertension as a high-risk clinical parameter in heart failure with preserved ejection fraction could pave a way forward for early intervention.
Heart Failure
Effect of Nonobstructive Coronary Artery Disease on Heart Failure Outcomes
Investigators sought to categorize patients with nonobstructive coronary artery disease and heart failure separately from patients with heart failure with normal coronary arteries, so as to more specifically analyze risk for cardiovascular hospitalization and all-cause mortality.
Higher FGF23 Predicts Worse Clinical Parameters in HF With Preserved EF
Fibroblast growth factor 23 levels above the median are independently associated with shorter 6-minute walk distance and lower peak oxygen consumption on exercise testing, study finds.
Gal-3 Predicts Risk for Post-Myocardial Infarction Mortality, Heart Failure
Investigators sought to determine whether galectin-3 may effectively predict mortality and heart failure after a myocardial infarction.
Smartphone/Smartwatch Devices Effective for Heart Failure Telemonitoring
Study demonstrated the feasibility of a newly designed mobile application for telemonitoring of patients after heart failure hospitalization.
Burden of Heart Failure-Related CVD Mortality Higher in African Americans
HealthDay News — The burden of heart failure-related cardiovascular disease (CVD) mortality is increased among young and middle-aged blacks, according to a research letter published in the May 14 issue of the Journal of the American College of Cardiology. Peter Glynn, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined…
FDA Approves Treatments for Heart Failure Caused by Rare Disease
Vyndaqel and Vyndamax capsules have been approved to treat adults with cardiomyopathy caused by transthyretin mediated amyloidosis.
First Treatments for Transthyretin Amyloid Cardiomyopathy Get FDA Approval
The FDA has approved Vyndaqel and Vyndamax for the treatment of the cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis.
Adherence to Plant-Based Diet Inversely Associated With Incident HF Risk
Higher adherence to a plant-based diet is associated with a lower risk for incident heart failure hospitalization.
Hypothyroidism a Risk Factor for Mortality in Congestive Heart Failure
Hypothyroidism is a risk factor for increased length of hospital stay and mortality in patients with congestive heart failure.
Next post in Heart Failure
